A recent experiment by the startup Nof1 revealed significant shortcomings in AI-managed investment strategies. The experiment involved giving $10,000 to eight leading AI tools, including ChatGPT and Claude, with the goal of trading US stocks over a two-week period. The results were stark: the collective portfolio lost approximately 33% of its value, dropping to $6,700.
The AI tools exhibited overtrading behavior and diverging strategies, leading to poor decisions. For instance, Grok, Elon Musk’s AI tool, executed 158 trades, while others had similar trading patterns with flawed decision-making due to their overconfidence in historical data. This experiment underscores that while AI can analyze vast amounts of data, it may fall short in real-world trading applications.
In contrast, Amgen (AMGN) is highlighted as a strong investment option due to its reliable dividend growth and solid financial performance, making it a favorable choice over volatile AI-driven strategies. Investors are advised to focus on companies like Amgen that show consistent returns rather than relying on AI models to manage their portfolios.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
